CLINICAL_TRIALS
trial_result
· 2019-09-20
Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis [Phase 3]
Summary
Phase 3 trial of sorafenib tosylate in desmoid fibromatosis (desmoid tumors) completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Desmoid Fibromatosis | Phase 3 | Status: COMPLETED | Results posted: 2019-09-20